About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Takeda Pharmaceutical Company Limited(4502) Summary

4502
TSE Prime
Takeda Pharmaceutical Company Limited
4,105
JPY
0
(0.00%)
Dec 23, 11:04 am JST
26.20
USD
Dec 22, 9:04 pm EST
Result
PTS
outside of trading hours
4,104
Dec 23, 11:03 am JST
Summary Chart Historical News Financial Result
PER
95.6
PBR
0.94
Yield
4.77%
Margin Trading Ratio
18.16
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
4,105 JPY 26.21 USD
Previous Close Dec 20
4,105 JPY 26.16 USD
High Dec 23, 9:00 am
4,114 JPY 26.28 USD
Low Dec 23, 9:29 am
4,088 JPY 26.11 USD
Volume
828,500
Trading Value
3.40B JPY 0.02B USD
VWAP
4101.76 JPY 26.22 USD
Minimum Trading Value
410,500 JPY 2,620 USD
Market Cap
6.53T JPY 0.04T USD
Number of Trades
1,342
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
4,574
1-Year High Aug 6, 2024
24,081
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 74,000 1,468,400 19.84
Dec 6, 2024 82,200 1,512,300 18.40
Nov 29, 2024 89,700 1,818,500 20.27
Nov 22, 2024 84,300 1,530,500 18.16
Nov 15, 2024 127,900 1,211,200 9.47
Company Profile
Takeda Pharmaceutical Company Limited is a leading pharmaceutical company. With the acquisition of Shire, it has become a global industry leader. The company focuses on prescription drugs and is strengthening its development of new cancer medications.
Sector
Pharmaceuticals